Cognitive dysfunction in schizophrenia: A new set of tools for the assessment of cognition and drug effects

Acta Psychiatrica Scandinavica, Supplement

Volumn 99, Issue 395, 1999, Pages 118-128

  Gallhofer, B ^a   Lis, S ^a   Meyer Lindenberg, A ^a   Krieger, S ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Cognition; Medication; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BUTYROPHENONE DERIVATIVE; CLOZAPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; RITANSERIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

BASAL GANGLION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; MAZE TEST; MOTOR CORTEX; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; PREFRONTAL CORTEX; RECEPTOR AFFINITY; SCHIZOPHRENIA; TASK PERFORMANCE; THALAMUS; BIOLOGICAL MODEL; BRAIN; COGNITION; DECISION MAKING; DEPTH PERCEPTION; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBLEM SOLVING; PSYCHOLOGY; REVIEW;

ANTIPSYCHOTIC AGENTS; BRAIN; COGNITION; COGNITION DISORDERS; DECISION MAKING; HUMANS; MAZE LEARNING; MODELS, NEUROLOGICAL; NEUROPSYCHOLOGICAL TESTS; NEUROTRANSMITTER AGENTS; PROBLEM SOLVING; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPACE PERCEPTION;

EID: 0032618156     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1999.tb05991.x     Document Type: Conference Paper

References (102)

1. KRAEPELIN E. Die Erscheinungen des Irreseins. A. Störungen der Wahrnehmung. In: Psychiatrie. Ein Lehrbuch für Studirende und Ärzte, Leipzig, Verlag von Johann Ambrosius Barth, Chapters II.A (Störungen des Wahrnehmungsvorganges) and B (Störungen der Verstandesthätigkeit) 1896:94-164.
2. KRAEPELIN E. (German original 1919, English translation 1971). Dementia praecox and paraphrenia. New York: Huntington, 1971.
3. BLEULER E. (German original 1911, English translation 1950) Dementia praecox or the group of schizophrenias. New York: International Universities Press, 1950.
4. KLEIST K. Über zykloide, paranoide und epileptoide Psychosen und über die Frage der Degenerationspsychosen. Schweiz Arch Neurol Psych 1928;23:1-35.
5. PRINZ W, SANDERS AF. Cognition and motor process. New York: Springer, 1984.
6. NEUMANN O, PRINZ W. Relationships between perception and action. Berlin: Springer, 1990.
7. ARBIB MA. The metaphorical brain 2. New York: John Wiley & Sons, 1989.
8. ARBIB MA. Levels of modeling of mechanisms of visually guided behaviour. Behav Brain Sci 1987;10:407-465.
9. BADDELEY A. Working memory. Oxford Psychology Series. Oxford: Clarendon Press, 1995.
10. BRAFF DL, GEYER MA. Sensorimotor gating and schizophrenia. Arch Gen Psychiatry 1993;47:181-188.
11. NORMAN DA, BOBROW DS. On data-limited and resource-limited processes. Cogn Psychol 1975;7:44-64.
12. SHIFFRIN RM, SCHNEIDER W. Controlled and automatic human information processing. II. Perceptual learning, automatic attending, and a general theory. Psychol Rev 1977;84:127-189.
13. SCHNEIDER W, SHIFFRIN RM. Controlled and automatic human information processing. I. Detection, search, and attention. Psychiatry Rev 1977;84:1-66.
14. NORMAN DA, SHALLICE T. Attention to action: willed and automatic control of behaviour. In: DAVIDSON RJ, SCHWARTZ GE, SHAPIRO E, ed. Consciousness and self-regulation. New York: Plenum Press, 1986:1-18.
15. SCHELL GR, STRICK PL. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas. J Neurosci 1984;2:539-560.
16. SELEMON LD, GOLDMAN-RAKIC PS. Longitudinal topography and interdigitation of corticostriatal projections in the Rhesus monkey. J Neurosci 1985;5:776-794.
17. ROBBINS TW, EVERITT BJ. Functions of dopamine in the dorsal and ventral striatum. Semin Neurosci 1992;00:119-128.
18. GOLDMAN-RAKIC PS. Circuitry of primate prefrontal cortex and regulation of behaviour by representational memory. In: MOUNTCASTLE VB, PLUM F, GEIGER SR, ed. Handbook of physiology. Vol. 1. New York: Oxford University Press, 1987:373-417.
19. GOLDMAN-RAKIC PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 1994;6:348-357.
20. BOGERTS B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull 1993;19:431-445.
21. ARNOLD SE, HYMAN BT, VAN HOSEN GW, DAMASIO AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991;48:625-632.
22. CONRAD AJ, ABEBE T, AUSTIN R, FORSYTHE S, SCHEIBEL AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991;48:413-417.
23. DELISI LE, TEW W, XIE S et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry 1995;15:349-360.
24. STEVENS JR. Neuropathology of schizophrenia. Arch Gen Psychiatry 1982;39:1131-1139.
25. KOLB B, WHISHAW IQ. Performance of schizophrenic patients on tests sensitive to the left or right frontal, temporal, or parietal function in neurological patients. J Nerv Mental Dis 1983;171:435-443.
26. FODOR JA. The modularity of mind. Cambridge, MA: MIT Press, 1983.
27. POSNER MI. Chronometric explorations of mind. Hillsdale, NJ: Erlbaum, 1978.
28. SHALLICE T. From neuropsychology to mental structure. New York: Cambridge University Press, 1988.
29. FARAH MJ. Neuropsychological interference with an interactive brains. A critique of the 'locality' assumption. Behav Brain Sci 1994;17:43-104.
30. GAZZANIGA MS, ed. The cognitive neurosciences. Cambridge, MA: Bradford/MIT Press, 1996.
31. CARLSSON A. Historical perspective of the chemistry and pharmacological treatment of schizophrenia. In: HENN FA, DELISI LE, ed. Handbook of schizophrenia. Vol. 2. Neurochemistry and neuropharmacology of schizophrenia. Amsterdam: Elsevier Science Publishers, 1987:1-15.
32. CARLSSON A. Speculations on the control of mental and motor functions by dopamine-modulated cortico-striatothalamo-cortical feedback loops. Mt Sinai J Med 1988;55:6-10.
33. CARLSSON A, CARLSSON M, SVENSSON A. Schizophrenia viewed as a neurotransmitter imbalance syndrome, involving dysregulation of sensory input and arousal. In: RACAGNI G, ed. Biological psychiatry. Amsterdam: Elsevier, 1991:467-468.
34. SEEMAN P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987;1:133-152.
35. BLEICH A, BROWN SL, KAHN R, VAN PRAAG, HM. The role of serotonin in schizophrenia. Schizophr Bull 1998;14:297-315.
36. LEVIN ED, MCGURK SR, ROSE JE, BUTCHERT LL. Cholinergic-dopaminergic interactions in cognitive performance. Behav Neural Biol 1990;54:271-299.
37. LIEBERMAN JA, KOREEN AR. Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophr Bull 1993;19:371-429.
38. SEDVALL G, FARDE L. Dopamine receptors in schizophrenia. Lancet 1996;347:264.
39. 2 dopamine receptor agonist. J Cogn Neurosci 1992;4:58-68.
40. BLEULER E. Dementia praecox oder Gruppe der Schizophrenien. Mit einem Vorwort von Manfred Bleuler, Nachdruck der Ausgabe Leipzig, Wien, Deuticke Tübingen: Ed. diskord 1911.
41. 1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991;251:947-950.
42. BUHOT MC. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 1997;7:243-245.
43. WOOLLEY DW, SHAW E. A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci USA 1954;40:228-231.
44. FREEDMAN DX. Hallucinogenic drug research: if so what? Symposium summary and commentary. Pharmacol Biochem Behav 1986;24:407-415.
45. BRAFF DL, GEYER MA. Acute and chronic LSD effects on rat startle: data sorting an LSD-rat model of schizophrenia. Biol Psychiatry 1980;15:909-916.
46. SNYDER SH. Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry 1972;34:169-179.
47. 2-antagonist 1985;27:600-611.
48. GELDERS Y, CEULEMANS DLS, HOPPENBROUWERS ML, REYNTJENS A, MESOTTEN F. Ritanserin. A selective serotonin antagonist in chronic schizophrenia. Proceedings of the Fourth World Congress of Biological Psychiatry, Philadelphia, PA, 1985:338.
49. GELDERS Y, CEULEMANS DLS, REYNTJENS A, HOPPENBROUWERS ML, FERANGE M. The influence of selective serotonin antagonists on conventional neuroleptic therapy. Proceedings of the Fourth World Congress of Biological Psychiatry, Philadelphia, PA, 1985:417.
50. COWARD DM. General pharmacology of clozapine. Br J Psychiatry 1992;17 (Suppl.):5-11.
51. HALL WB, VESTRE ND, SCHIELE BC, ZIMMERMANN R. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics. Dis Nerv System 1968;29:405-408.
52. AYD FJ. Comparative trial of low-dose haloperidol and fluphenazine in office patients. Dis Nerv System 1972;33:192-195.
53. GOLDSTONE S, NURNBERG HG, LHAMON WT. Effects of trifluoperazine, chlorpromziene and haloperidol upon temporal information-processing by schizophrenic patients. Psychopharmacology 1979;65:119-124.
54. MUNGAS D, MAGLIOZZI JR, LAUBLY JN, BLUNDEN D. Effects of haloperidol on recall and information-processing in verbal and spatial learning. Progr Neuropsychopharmacol Biol Psychiatry 1990;14:181-193.
55. PALAO DJ, ARAUXO A, BRUNET M et al. Positive versus negative symptoms in schizophrenia: response to haloperidol. Prog Neuropsychopharmacol Biol Psychiatry 1993;18:155-164.
56. BALDESSARINI R, FRANKENBURG FR. Clozapine: a novel antipsychotic drug. N Engl J Med 1991;324:746-754.
57. 1 and muscarinic acetylcholine receptors. In: YAMAMURA HI, OLSEN RW, USDIN E, ed. Developments in neuroscience. Vol. 11. Psychopharmacology and biochemistry of neurotransmitter receptors. New York: Elsevier, 1980:263-277.
58. NUECHTERLEIN KH. Reaction time and attention in schizophrenia: a critical evaluation of the data and theories. Schizophr Bull 1977;3:373-428.
59. NUECHTERLEIN KH, DAWSON ME. Information-processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984;10:160-203.
60. DUBOIS B, VERIN M, TEIXEIRA-FERREIRA C, SIRIGU A, PILLON B. How to study frontal lobe functions in humans. In: THIERRY AM, GLOWINSKI J, GOLDMAN-RAKIC PS, CHRISTEN Y, ed. Motor and cognitive functions of the prefrontal cortex. Berlin: Springer, 1994:1-18.
61. WEINBERGER DR, BERMAN KF, ZEC RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114-124.
62. MÜLLER WE, TUSCHI R, GIETZEN K. Therapeutische und unerwünschte Wirkungen von Neuroleptika - die Bedeutung von Rezeptorprofilen. Psychopharmakotherapie 1995;4:148-153.
63. SMALL WS. Experimental study of the mental processes of the rat. II. Am J Psychol 1901;12:206-239.
64. BALKENIUS C. Natural intelligence in artificial creatures. Lund: Lund University Cognitive Studies, 1995.
65. MILNER B. Visually guided maze learning in man: effects of bilateral hippocampal, bilateral frontal and unilateral cerebral lesions. Neuropsychologia 1965;3:317-338.
66. WINOCUR G, MOSCOVITCH M. Hippocampal and prefrontal cortex contribution to learning and memory: analysis of lesion and aging effects on maze learning in rats. Behav Neurosci 1990;104:544-551.
67. JONES B, MISHKIN M. Limbic lesions and the problem of stimulus-reinforcement associations. Exp Neurol 1972;36:363-377.
68. DAUM I, SCHUGENS MM, CHANNON S, POLKEY CE, GRAY JA. T-maze discrimination and reversal learning after unilateral temporal or frontal lobe lesions in man. Cortex 1991;27:613-622.
69. PORTEUS SD, DEMONBRUN R, KEPNER MD. Mental changes after bilateral prefrontal leucotomy. Genet Psychol Monogr 1944;29:23-115.
70. CANAVAN AGM. Stylus-maze performance in patients with frontal lobe lesions: effects of signal valency and relationship to verbal and spatial abilities. Neuropsychologia 1983;21:375-382.
71. KARNATH HO, WALLESCH CW, ZIMMERMANN P. Mental planning and anticipatory processes with acute and chronic frontal lobe lesions: a comparison of maze performance in routine and non-routine situations. Neuropsychologia 1991;29:271-290.
72. ROLLS ET. Neurophysiology and cognitive functions of the striatum. Rev Neurol Paris 1994;150:648-660.
73. JOELD, WEINER I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience 1994;63:363-379.
74. MEGA MS, CUMMINGS JL. Frontal-subcortical circuits and neuropsychiatrie disorders. J Neuropsychiatr Clin Neurosci 1994;6:358-70.
75. GALLHOFER B, BAUER U, GRUPPE H, KRIEGER S, LIS S. First-episode schizophrenia: the importance of compliance and preserving cognitive function. J Pract Psychiatry Behav Health 1996:16-24.
76. GALLHOFER B, BAUER U, LIS S, KRIEGER S, GRUPPE H. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacology 1996;6:14-20.
77. GALLHOFER B, KRIEGER S, LIS S et al. Cognitive dysfunction in schizophrenia: maze-solving behavior in treated and untreated patients. CNS Spectrums 1997;8:26-42.
78. CHAPUIS F. Der Labyrinth-Test. Bern: Hans Huber, 1959.
79. OSWALD WD, FLEISCHMAN UM. Nürnberger Alters-Inventar, 1990.
80. ANNETT M. The binomial distribution of right, mixed and left-handedness. J Exp Psychol 1967;19:327-333.
81. OVERALL JE, GORHAM DR. Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
82. COOK TD, CAMPBELL DT. Quasi-experimentation. Design and analysis issues for field settings. Chicago: Rand McNally College Publishing Company, 1979.
83. MESOTTEN F, SUY E, PIETQUIN M, BURTON P, HEYLEN S, GELDERS Y. Therapeutic effect and safety of increasing doses of risperidone (R64766) in psychotic patients. Psychopharmacology 1989;99:445-449.
84. MELTZER HY. Dimensions of outcome with clozapine. Br J Psychiatry 1992;160:46-53.
85. GOLDBERG TE, GREENBERG RD, GRIFFIN SJ et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-48.
86. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn. Washington, DC: American Psychiatric Press, 1987.
87. HEATON R. Wisconsin Card Sorting manual. Odessa, FL: Psychological Assessment Resources, 1981.
88. GOLDBERG TE, WEINBERGER DR, BERMAN KF, PLISKIN NH, PODD MH. Further evidence for dementia of the prefrontal type in schizophrenia. A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 1987;44:1008-1014.
89. GREEN MF, SATZ P, GANZELL S, VACLAV JF. Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit. Am J Psychiatry 1992;149:62-67.
90. ABBRUZZESE M, BELLODI L, FERRI S, SCARONE S. Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cogn 1995;27:202-212.
91. FRITH CD, DONE DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry 1988;153:437-443.
92. FRITH CD, DONE DJ. Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action. Psychol Med 1989;19:359-363.
93. LURIA AR, HOMSKAYA ED, BLINKÓV SM, CRITCHLEY M. Impaired selectivity of mental processes in association with a lesion of the frontal lobe. Neuropsychologia 1967;5:105-117.
94. MURPHY TJ, DEWOLFE AS. Planning abilities in alcoholics, process and reactive schizophrenics, and normals. Int J Addict 1989;24:435-444.
95. FRANZ M, LIS S, PLUDDEMANN K, GALLHOFER B. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. Br J Psychiatry 1997;170:422-425.
96. LEVIN S, YURGELUN-TODD D, CRAFT S. Contributions of clinical neuropsychology to the study of schizophrenia. J Abnorm Psychol 1989;98:341-56.
97. NEISSER U. Cognitive psychology. New York: Appleton, 1967.
98. PORTEUS SD. Porteus mazes test: fifty years' application. Palo Alto, CA: Pacific, 1965.
99. PRINZ W, BRIDGEMAN B, HEUER H, KEELE SW, NEUMANN O, SANDERS AF. Handbook of perception and action. London: Academic Press, 1995.
100. RUMELHARDT DE, SMOLENSKY P, MCCLELLAND JL, HlNTON GE. Schemata and sequential thought processes in PDP models. In: RUMMELHARDT DE, MCCLELLAND JL, ed. Parallel distributed processes. Cambridge, MA: MIT Press, 1986:7-57.
101. SHALLICE T. Specific impairments of planning. Phil Trans R Soc Lond B 1982;298:199-209.
102. STEWART I. The magical maze. London: Weidenfeld and Nicolson, 1997.